Revenue (Tables)

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregated Revenue

The following table presents our disaggregated revenue for the periods presented (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Immune Medicine revenue
Service revenue	$	5,238	$	6,559	$	17,848	$	20,968
Collaboration revenue		8,013		21,320		34,667		50,105
Total Immune Medicine revenue		13,251		27,879		52,515		71,073
MRD revenue
Service revenue		24,668		19,951		71,977		55,037
Regulatory milestone revenue		—		—		—		4,000
Total MRD revenue		24,668		19,951		71,977		59,037
Total revenue	$	37,919	$	47,830	$	124,492	$	130,110